Beckman Laser Institute Medical Clinic
Irvine, California, 92612, United States
NCT Number: NCT01775722
Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin. However, even though the pulsed dye laser is considered as the treatment of choice for Port wine stain Birthmark the degree of fading can remain variable and unpredictable after laser treatment.
Looking for future studies?
Notify Me12 year and older
All sexes
Interventional
Not applicable
Irvine, California, 92612, United States
The researcher want to use the combination of radiofrequency electrical energy with pulsed dye laser light energy which can improve therapeutic outcome of Port wine stain Birthmark. This investigational device is essentially a combination of two commercially available systems cleared for marketing (K044351 and K052324) provided by Candela Laser Corporation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
port wine stain
Other names: candela-Laser
Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment
Time frame: 8 weeks
Port Wine Stain blood volume fractions in the skin before (fB1), and 8 weeks after (fB2) treatment will be determined using the corresponding visual reflectance spectra measured at the treatment sites. The primary outcome, degree of blanching, B, is computed as B = (fB1-fB2)/fB1.
University of California, Irvine
Other
Combined Bipolar Radiofrequency and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06875492
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Xi'an, Shaanxi, China
View Trial DetailsNCT03181984
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Harbin, Heilongjiang, China
View Trial DetailsNCT04106258
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT02051101
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Irvine, California, United States
View Trial Details